Metabolic Acidosis Results in Sexually Dimorphic Response in the Heart Tissue

Yamin Liu1, Amina Atiq1, Anna Peterson1

  • 1Department of Biomedical Engineering, University of Connecticut Health, Farmington, CT 06032, USA.

Metabolites
|April 28, 2023
PubMed

Insights

Low-grade metabolic acidosis (MA) impacts the heart, altering genes differently in male and female mice. This study reveals sex-specific cardiovascular changes, offering insights into managing MA-related heart damage.

Area of Science:

  • Cardiovascular Physiology
  • Metabolic Disorders
  • Transcriptomics

Background:

  • Metabolic acidosis (MA) is a prevalent blood pH imbalance affecting the heart.
  • The heart's limited regeneration and high metabolic rate make it susceptible to chronic low-grade MA.
  • Understanding MA's cardiac effects is crucial for managing associated health risks.

Purpose of the Study:

  • To systematically investigate the cardiac effects of low-grade metabolic acidosis.
  • To identify gender-based differences in MA-induced cardiovascular gene expression.
  • To establish a systems-level understanding of MA's impact on cardiovascular tissue.

Main Methods:

  • Male and female mice were treated with ammonium chloride (NH4Cl) for two weeks to induce low-grade MA.
  • Blood chemistry was analyzed to confirm MA and assess physiological compensation.
  • Cardiac tissue transcriptomic analysis was performed to identify gene expression changes.

Main Results:

  • Low-grade MA was confirmed by reduced blood pH and bicarbonate levels with minimal respiratory compensation.
  • Significant gender-based differences were observed in cardiac gene expression profiles.
  • Males showed alterations in genes linked to dilated cardiomyopathy, while females exhibited changes in cardiac contractility and Na/K/ATPase-Src signaling.

Conclusions:

  • Low-grade MA induces distinct cardiovascular transcriptomic changes in male and female mice.
  • These findings highlight sex differences in MA-related cardiac damage.
  • The study provides a foundation for developing targeted interventions to mitigate MA-induced cardiovascular pathology.